These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 17314403)
1. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Cui CH; Uyama T; Miyado K; Terai M; Kyo S; Kiyono T; Umezawa A Mol Biol Cell; 2007 May; 18(5):1586-94. PubMed ID: 17314403 [TBL] [Abstract][Full Text] [Related]
2. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model. Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121 [TBL] [Abstract][Full Text] [Related]
3. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy. Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755 [TBL] [Abstract][Full Text] [Related]
8. Cells of extraembryonic mesodermal origin confer human dystrophin in the mdx model of Duchenne muscular dystrophy. Kawamichi Y; Cui CH; Toyoda M; Makino H; Horie A; Takahashi Y; Matsumoto K; Saito H; Ohta H; Saito K; Umezawa A J Cell Physiol; 2010 Jun; 223(3):695-702. PubMed ID: 20162617 [TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice. Zhang Y; Long C; Li H; McAnally JR; Baskin KK; Shelton JM; Bassel-Duby R; Olson EN Sci Adv; 2017 Apr; 3(4):e1602814. PubMed ID: 28439558 [TBL] [Abstract][Full Text] [Related]
10. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261 [TBL] [Abstract][Full Text] [Related]
11. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
12. Long-term effect of human mini-dystrophin in transgenic mdx mice improves muscle physiological function. Chu X; Li J; Qiao C; Wang J; Wang Y; Jiang XC; You H; Xiao X; Wang B FASEB J; 2021 Jun; 35(6):e21628. PubMed ID: 33982338 [TBL] [Abstract][Full Text] [Related]
13. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector. Bujold M; Caron N; Camiran G; Mukherjee S; Allen PD; Tremblay JP; Wang Y Cell Transplant; 2002; 11(8):759-67. PubMed ID: 12588108 [TBL] [Abstract][Full Text] [Related]
14. Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy. Kimura E; Han JJ; Li S; Fall B; Ra J; Haraguchi M; Tapscott SJ; Chamberlain JS Hum Mol Genet; 2008 Aug; 17(16):2507-17. PubMed ID: 18511457 [TBL] [Abstract][Full Text] [Related]
15. [Gene therapy for muscular dystrophy]. Takeda S No To Hattatsu; 2004 Mar; 36(2):117-23. PubMed ID: 15031985 [TBL] [Abstract][Full Text] [Related]
16. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy. Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609 [TBL] [Abstract][Full Text] [Related]
17. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy. Guo Y; Petrof BJ; Hussain SN Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948 [TBL] [Abstract][Full Text] [Related]
18. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro. Vieira NM; Brandalise V; Zucconi E; Jazedje T; Secco M; Nunes VA; Strauss BE; Vainzof M; Zatz M Biol Cell; 2008 Apr; 100(4):231-41. PubMed ID: 17997718 [TBL] [Abstract][Full Text] [Related]
19. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy. Ito M; Ehara Y; Li J; Inada K; Ohno K Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975 [TBL] [Abstract][Full Text] [Related]
20. Live-imaging of revertant and therapeutically restored dystrophin in the Dmd Petkova MV; Stantzou A; Morin A; Petrova O; Morales-Gonzalez S; Seifert F; Bellec-Dyevre J; Manoliu T; Goyenvalle A; Garcia L; Richard I; Laplace-Builhé C; Schuelke M; Amthor H Neuropathol Appl Neurobiol; 2020 Oct; 46(6):602-614. PubMed ID: 32573804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]